Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases

被引：0
|
作者：
Nakamura, Shoko [1 ]
Tomisato, Kota [1 ]
Teramoto, Akira [1 ]
Kondo, Akiyuki [1 ]
Matsukawa, Shinobu [1 ]
Yabutani, Akira [1 ]
Iraha, Atsushi [1 ]
Kobashikawa, Kasen [1 ]
Nakamura, Masamoto [1 ]
Nakayoshi, Tomokuni [1 ]
Uchima, Nobufumi [1 ]
Kinjo, Fukunori [1 ]
机构：
[1] Urasoe Gen Hosp, Urasoe City, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
neuroendocrine tumor; liver metastases;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-623
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [31] Baseline and dynamic plasma chromogranin A (CgA) level to predict clinical outcome and tumor response in Asian patients with gastroenteropancreatic neuroendocrine tumor (GEP-NET).
    Chou, Wen-Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in a Single Institute in North Africa over the Last 16 Years
    Harhira, I
    Yahyaoui, Y.
    Chrait, N.
    Mghirbi, F.
    Letaief, F.
    Gabsi, A.
    Meddeb, K.
    Ayadi, A.
    Mokrani, A.
    Raies, H.
    Mezlini, A.
    NEUROENDOCRINOLOGY, 2020, 110 : 78 - 78
  • [33] EFFICACY OF LONG-ACTING SOMATOSTATIN ANALOGUES (SA) IN PATIENTS (PTS) WITH HIGHLY DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP NETS)
    Markovich, Alla
    Galina, Emelyanova
    Vera, Gorbunova
    Nadezhda, Orel
    Alexander, Kuzminov
    Anastasia, Odintsova
    Armen, Margaryan
    ANNALS OF ONCOLOGY, 2014, 25
  • [34] Damaging germline variants in TSC2 are frequently found among nonsyndromic patients with gastroenteropancreatic (GEP) neuroendocrine tumors (NETs)
    Linck, R. D. M.
    Asprino, P. F.
    Freitas, F. P.
    Koyama, F. C.
    Galante, P. A. F.
    Riechelmann, R.
    Reis, L. F. L.
    Costa, F. P.
    Hoff, P. M.
    Camargo, A. A.
    Sabbaga, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Efficace of long-acting somatostatin analogues (SA) in patients (pts) with highly differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs)
    Markovich, Alla
    Nadezhda, Orel
    Armen, Margaryan
    Alexander, Kuzminov
    Galina, Emelyanova
    Anastasia, Odintsova
    Vera, Gorbunova
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] High Prevalence of Sarcopenia in Patients with Newly Diagnosed Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs), but No Association with the Risk of Surgical Complications
    Clement, Dominique S. V. M.
    van Leerdam, Monique E.
    Tesselaar, Margot E. T.
    Srinivasan, Parthi
    Menon, Krishna
    Kuhlmann, Koert
    den Hartog, Anne
    Giovos, George
    Weickert, Martin O.
    Srirajaskanthan, Rajaventhan
    NUTRIENTS, 2024, 16 (22)
  • [37] Ten Years of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Evolution of Classification and Correlation with Follow-up in 50 Patients
    Grillo, F.
    Albertelli, M.
    Giannone, A.
    Mastracci, L.
    Annunziata, F.
    Arvigo, M.
    Minuto, F.
    Fiocca, R.
    Ferone, D.
    NEUROENDOCRINOLOGY, 2012, 96 : 33 - 33
  • [38] Quantitative Detection of Survivin Protein in the Serum of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients - A Promising Biomarker?
    Georgieva, I
    Blaeker, M.
    Wang, Y.
    Kiewe, P.
    Zeitz, M.
    Grabowski, P.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 114 - 114
  • [39] CONTEMPORARY PATTERNS AND OUTCOMES OF LIVER-DIRECTED THERAPY IN PATIENTS WITH GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS AND LIVER METASTASES
    Strong, Erin A.
    Gracz, Maciej
    Livingston, Austin
    Barnes, Chad
    Clarke, Callisia N.
    GASTROENTEROLOGY, 2020, 158 (06) : S1563 - S1564
  • [40] Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
    Kim, Seung Tae
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Lee, Jeeyun
    Park, Young Suk
    JOURNAL OF CANCER, 2016, 7 (09): : 1044 - 1048
12345